Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Masoomeh Yarahmadi"'
Autor:
Marjan Shokrani, Sanaz Askari, Negin Eissazade, Seyed Vahid Shariat, Behnam Shariati, Masoomeh Yarahmadi, Mohammadreza Shalbafan
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background As 40–60% of the patients with obsessive-compulsive disorder (OCD) do not adequately respond to the first-line treatment, finding an effective second-line treatment is required. Our aim was to assess the efficacy and safety of a
Externí odkaz:
https://doaj.org/article/9ee89aa0db18498d85d2a670e236d3e6
Autor:
Seyed Mani Mahdavi, Behnam Shariati, Mohammadreza Shalbafan, Vahid Rashedi, Masoomeh Yarahmadi, Alireza Ghaznavi, Shayan Amiri
Publikováno v:
BMC Pharmacology and Toxicology, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background Although various pharmacological and nonpharmacological treatments are available for the chronic low back pain (CLBP), there is no consensus on the best optimal treatment for this condition. This study aimed to investigate the eff
Externí odkaz:
https://doaj.org/article/149241a6fbfc4269a7cbd991654ad943
Autor:
Ala Ghobadian, Saba Mokhtari, Behnam Shariati, Leila Kamalzadeh, Mohsen Shati, Mehrdad Eftekhar Ardebili, Masoomeh Yarahmadi, Mohammadreza Shalbafan
Publikováno v:
BMC Pharmacology and Toxicology, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Medications currently recommended for the treatment of Obsessive-Compulsive Disorder (OCD) usually relieve the severity of symptoms by as much as 20–30%, and satisfactory treatment is obtained in 40–60% of patients with OCD. N
Externí odkaz:
https://doaj.org/article/2e172342d5924769a2a5ecf74c556aa4
Autor:
Sanaz Askari, Saba Mokhtari, Seyed Vahid Shariat, Behnam Shariati, Masoomeh Yarahmadi, Mohammadreza Shalbafan
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Medications currently recommended for the treatment of Obsessive-Compulsive Disorder (OCD) usually decrease the severity of the symptoms by 20–30%; however, 40–60% of OCD patients do not achieve a satisfactory response. Our ma
Externí odkaz:
https://doaj.org/article/de00ea1682674117ac90d7e9ddfa11cc
Autor:
Hossein Sanjari Moghaddam, Amirhossein Poopak, Mohammad Mehdi Pirmoradi, Saba Hoobehfekr, Maryam Ghazizadeh Hashemi, Mohammadreza Shalbafan, Shahin Akhondzadeh, Masoomeh Yarahmadi, Shayan Kashefinejad, Amirhossein Sakenian
Publikováno v:
Psychiatry and Clinical Neurosciences. 75:57-62
Aim Tipepidine, a synthetic, non-opioid expectorant, has been shown to improve depressive-like behavior in animal models of depression. In this study, we assessed the efficacy and tolerability of tipepidine combination therapy with citalopram in trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a5500e38b1a514cab307d4fc84712a6
https://doi.org/10.1111/pcn.13180
https://doi.org/10.1111/pcn.13180
Publikováno v:
Journal of Iranian Medical Council.
Background: Based on the proven role of sleep quality in promoting health, the treatment of insomnia should be premised on identification of characteristics and severity of insomnia symptoms. This study aimed to investigate the effectiveness of Cogni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7761e1521342af0fa66f2f6a0ff6a221
https://doi.org/10.18502/jimc.v4i4.8487
https://doi.org/10.18502/jimc.v4i4.8487
Autor:
Ala Ghobadian, Saba Mokhtari, Behnam Shariati, Leila Kamalzadeh, Mohsen Shati, Mehrdad Eftekhar Ardebili, Masoomeh Yarahmadi, Mohammadreza Shalbafan
Background: Medications currently recommended for the treatment of Obsessive-Compulsive Disorder (OCD) usually relieve the severity of symptoms by as much as 20–30%, and satisfactory treatment is obtained in 40–60% of patients with OCD. Neverthel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::245c1d6389c02f53cdbb5e3ea4465d3f
https://doi.org/10.21203/rs.3.rs-1135729/v1
https://doi.org/10.21203/rs.3.rs-1135729/v1
Autor:
Ala Ghobadian, Saba Mokhtari, Behnam Shariati, Leila Kamalzadeh, Mohsen Shati, Mehrdad Eftekhar Ardebili, Masoomeh Yarahmadi, Mohammadreza Shalbafan
Publikováno v:
BMC pharmacologytoxicology. 23(1)
Background Medications currently recommended for the treatment of Obsessive-Compulsive Disorder (OCD) usually relieve the severity of symptoms by as much as 20–30%, and satisfactory treatment is obtained in 40–60% of patients with OCD. Neverthele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470d2c2ba9c0683644d6f4de9c52cc9c
https://pubmed.ncbi.nlm.nih.gov/36167636
https://pubmed.ncbi.nlm.nih.gov/36167636
Autor:
Sanaz Askari, Behnam Shariati, Mohammadreza Shalbafan, Seyed Vahid Shariat, Saba Mokhtari, Masoomeh Yarahmadi
Background: Medications currently recommended for the treatment of Obsessive-Compulsive Disorder (OCD) usually decrease the severity of the symptoms by 20–30%, and 40–60% of OCD patients do not achieve satisfactory treatment. In this study, the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e5b4536d03397b8726428aef8e75f9b
https://doi.org/10.21203/rs.3.rs-647493/v1
https://doi.org/10.21203/rs.3.rs-647493/v1